Rituximab-induced interstitial lung disease: case report and literature review |
| |
Authors: | Zayen Aymen Rais Henda Rifi Hela Ouarda Mouna Afrit Mehdi Cherif Aziz Mezline Amel |
| |
Institution: | Salah Azaiez Institute, Tunis, Tunisia. aymen.zayen@laposte.net |
| |
Abstract: | Rituximab, a chimeric monoclonal antibody against CD20, very rarely causes lung toxicity. Toxicity may present as interstitial lung disease, alveolar hemorrhage and adult respiratory distress syndrome. Sixteen cases of rituximab-induced interstitial lung disease (R-ILD) have been reported. With this case and a review of all other cases reported in the literature, we will try to identify the features of R-ILD, its treatment and why the early diagnosis of this complication is important. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|